Clinical research on the cold-cycle microwave ablation in combination with TACE in the treatment of primary hepatocarcinoma
Yu Guozheng,Liao Zijun,Qiu Fakai,Li Chaowei,Li Xiaolong,Zhang Wenjuan,Xu Xianyan
DOI: https://doi.org/10.3969/j.issn.1672-4992.2013.06.42
2013-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the efficacy and safety of the cold-cycle microwave ablation in combination with TACE in treating primary hepatocarcinoma.Methods:Forty-five cases of primary hepatocarcinoma were chosen.They were treated with trans-hepatic arterial in fusion chemotherapy and embolism(TACE).Most chemotherapeutic regimens were two-agent combinations(EPI+CDDP,GEM+CDDP or 5-FU+CDDP),and embolism agents included superliquid lipiodol(dose was given based on the volume and blood supply of tumor and hepatic function,usually 5 to 15 ml) and gelatin sponge.Patients whose tumors were well lipiodol-deposited were treated with TACE once a month for two to three times,then their reciduary foci were further treated with cold-cycle microwave ablation(power was 50 to 60W,each locus should be treated for 20 to 30 minutes).For patients whose tumors were badly lipiodol-deposited because of poor blood supply,they received cold-cycle microwave ablation after the first TACE(with the same power and time as those aforementioned).When all treatments finished,alterations of embolism/melt degree of loci,clinical symptoms,AFP and liver/kidney functions and blood regular test were evaluated by weighted CT,MR or DSA(digital subtract angiography) tests.Follow-up time was 3 years after the last treatment.Results:Among 45 patients with primary hepatocarcinoma,34 cases had hypervascular tumors and underwent TACE treatment,including 0 of CR,70.6%(24 of 34) of PR,17.6%(6 of 34) of SD and 11.8%(4 of 34) of PD,which achieved a clinical beneficial rate of 88.2%.Up to 62 hypervascular and hypovascular loci remained after TACE treatment.Under cold-cycle microwave ablation therapy,complete necrosis of loci occurred in 48 cases(77.4%),incomplete necrosis of loci occurred in 5 cases(8.1%) and partial necrosis of loci occurred in 9 cases(14.5%).11 cases had AFP beyond 400μg/L prior to cold-cycle microwave ablation therapy,AFP of 7 cases dropped to normal level,AFP of 2 cases decreased significantly compared with that of pretreatment,2 cases showed no change in AFP.The 1-,2-and 3-year survival rates were 73.3%,62.2% and 37.8%,respectively.The main chemotherapy-associated side effects included nausea,vomiting and anorexia,aleucocytosis and thrombocytopenia were within grade Ⅱ to Ⅲ.Embolism and microwave ablation related effects were local pain(NRS 4 to 6) and fever(mild to moderate).Overall,the above adverse effects were fully relieved after sympotomatic treatment,without severe complications and surgery-related deaths.Conclusion:In the therapy of primary hepatocarcinoma,imaging-guided cold-cycle microwave ablation in combination with TACE showed merits of obvious curative effect,little trauma,high safety and easy operation,which made it an effective combined minimally-invasive treatment method in targeting primary hepatocarcinoma.